AML is a common hematological malignancy in adults. Despite many advances, the malignancy still carries a poor prognosis. Hence, it is best managed by a multidisciplinary team that includes a hematologist, oncologist. internist, pathologist,Â and an intensivist. The oncology nurse is vital for treatment administration and monitoring for potential complications. The pharmacist should educate the patient on potential adverse effects of the potent drugs used to treat this malignancy. The primary care physician should educate the patient on personal hygiene, hand washing, and immunization. Overall, the life expectancy has increased slightly but most patients have a markedly shortened lifespan.